These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9587036)

  • 141. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
    Stanger O; Weger M; Renner W; Konetschny R
    Clin Chem Lab Med; 2001 Aug; 39(8):725-33. PubMed ID: 11592442
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Hyperhomocysteinaemia and end stage renal disease.
    Gupta A; Robinson K
    J Nephrol; 1997; 10(2):77-84. PubMed ID: 9238614
    [TBL] [Abstract][Full Text] [Related]  

  • 143. [Role of nitric oxide and other endothelium-derived factors].
    Stankevicius E; Kevelaitis E; Vainorius E; Simonsen U
    Medicina (Kaunas); 2003; 39(4):333-41. PubMed ID: 12738901
    [TBL] [Abstract][Full Text] [Related]  

  • 144. The case for mild hyperhomocysteinaemia as a risk factor.
    Boers GH
    J Inherit Metab Dis; 1997 Jun; 20(2):301-6. PubMed ID: 9211202
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Putative mechanisms for vascular damage by homocysteine.
    Bellamy MF; McDowell IF
    J Inherit Metab Dis; 1997 Jun; 20(2):307-15. PubMed ID: 9211203
    [TBL] [Abstract][Full Text] [Related]  

  • 146. The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications.
    Blann AD; Lip GY
    Blood Coagul Fibrinolysis; 1998 Jun; 9(4):297-306. PubMed ID: 9690800
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
    Oussalah A; Guéant JL; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2011 Nov; 34(10):1173-84. PubMed ID: 21967576
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Primary endothelial dysfunction: atherosclerosis.
    Shimokawa H
    J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated.
    Kaul S; Zadeh AA; Shah PK
    J Am Coll Cardiol; 2006 Sep; 48(5):914-23. PubMed ID: 16949480
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Annexin II and regulation of cell surface fibrinolysis.
    Hajjar KA; Acharya SS
    Ann N Y Acad Sci; 2000 May; 902():265-71. PubMed ID: 10865846
    [TBL] [Abstract][Full Text] [Related]  

  • 151. [The vascular endothelium: physiopathology and participation in thrombogenesis].
    Chordá C; Páramo JA
    Sangre (Barc); 1995 Dec; 40(6):491-8. PubMed ID: 8850233
    [No Abstract]   [Full Text] [Related]  

  • 152. Homocysteine. The association with atherosclerotic vascular disease in older persons.
    Aronow WS
    Geriatrics; 2003 Sep; 58(9):22-4, 27-8. PubMed ID: 14518174
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease.
    Selwyn AP; Kinlay S; Creager M; Libby P; Ganz P
    Am J Cardiol; 1997 Mar; 79(5A):17-23. PubMed ID: 9127617
    [TBL] [Abstract][Full Text] [Related]  

  • 154. [Homocysteine and cardiovascular risk].
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
    Boers GH
    Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'.
    Lip GY; Blann AD
    Ann Med; 2004; 36(2):119-25. PubMed ID: 15119831
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Lipoproteins and the haemostatic system in atherothrombotic disorders.
    Miller GJ
    Baillieres Best Pract Res Clin Haematol; 1999 Sep; 12(3):555-75. PubMed ID: 10856985
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Homocysteine and hypomethylation. A novel link to vascular disease.
    Lee ME; Wang H
    Trends Cardiovasc Med; 1999; 9(1-2):49-54. PubMed ID: 10189967
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Homocysteine and arterial disease. Experimental mechanisms.
    Cook JW; Taylor LM; Orloff SL; Landry GJ; Moneta GL; Porter JM
    Vascul Pharmacol; 2002 May; 38(5):293-300. PubMed ID: 12487034
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Coronary risk factors, endothelial function, and atherosclerosis: a review.
    Vogel RA
    Clin Cardiol; 1997 May; 20(5):426-32. PubMed ID: 9134272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.